At HIMSS18, Philips plans to announce several new additions to its line of connected care products. A new management system called FocusPoint will help give hospitals more visibility into the performance of their patient monitoring technology.
Philips also plans to introduce the next generation of its HealthSuite collection of digital health tools, which will include analytics and artificial...
The market for digital dose inhalers for asthma and COPD will be worth $3.56 billion in 2024, according to a new prediction from Grand View Research.
Though connected inhalers are a new market, they've seen rapid growth in the last few years with interest from big pharma companies like AstraZeneca and Novartis, major device companies like Philips Respironics, as well as the newer, smaller...
According to a new study, users of Philips Respironics' SleepMapper app were 22 percent more adherent to continuous positive airway pressure (CPAP) therapy than non-users.
SleepMapper is an app and website platform from Philips for patients with sleep apnea who are already using CPAP therapy, which involves a face mask that blows air into a patient's upper airway while she sleeps. The system,...
Philips Respironics has included wireless connectivity in its CPAP (continuous positive airway pressure) machines for people with obstructive sleep apnea for going on four years now. The machines have transmitted data to healthcare providers who could remotely check-in on their patients and make adjustments to their machines and therapy as needed. With the launch of a new app, called SleepMapper...
